FY26 Annual Report
Filed with ASX · · 42 pages · English
Summary by 6ix AI
The company reported a net loss after tax, which is significantly lower than the previous year's loss, indicating some improvement. No dividends were declared during the financial period, and the company has not conducted trading operations since divesting its businesses in the prior year. The report highlights ongoing challenges, including a reliance on recapitalization strategies and the need for additional funding to ensure future viability.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Quarterly Activities/Appendix 4C Cash Flow Report June 2026
- FY25 Appendix 4E & Annual Report
- Suspension from Official Quotation - Annual Listing Fees
- Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025
- Quarterly Activities/Appendix 4C Cash Flow Report June 2025
Later from Genetic Technologies
All Genetic Technologies news releasesFollow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies